Sort
27,075 grants matching “cholesterol”
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome
$362,318William P Fay · University Of Missouri-Columbia · R01 · FY2019 · HL
Obesity and Metabolic Risk Disparities: Underlying Food Environment Factors
$362,255Penny Gordon-Larsen · Univ Of North Carolina Chapel Hill · R01 · FY2014 · HL
Functional studies of KLF-14, a putative master regulator of metabolism
$362,250Kiran Musunuru · University Of Pennsylvania · R01 · FY2018 · DK
Functional studies of KLF-14, a putative master regulator of metabolism
$362,250Kiran Musunuru · University Of Pennsylvania · R01 · FY2017 · DK
Structural interrogation of allosteric AMPK regulation
$362,224Karsten Melcher · Van Andel Research Institute · R01 · FY2015 · GM
Molecular regulation of the AP2 clathrin adaptor complex
$362,181Gunther Hollopeter · Cornell University · R01 · FY2022 · GM
AGE OF DEMENTIA ONSET AND CARDIOVASCULAR RISK FACTORS
$362,159Mount Sinai School Of Medicine Of Nyu · P01 · FY2005 · AG
Regulation Of Neutral Lipid Metabolism in Adipocytes and other cells.
$362,143Constantine Londos · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Exosites in Matrix Metalloproteinase Localization and Activity
$362,135Steven R Van Doren · University Of Missouri-Columbia · R01 · FY2012 · GM
CRIC Ancillary Study: Carbamylated low-density lipoprotein and cardiovascular eve
$362,113Sudhir V Shah · Univ Of Arkansas For Med Scis · R01 · FY2010 · HL
ACAT FUNCTIONS USING KNOCKOUT MICE
$362,076J. David Gladstone Institutes · R01 · FY2001 · HL
Metabolism of Carcinogens and Drugs by Human P450s
$362,040F Peter Guengerich · Vanderbilt University · R37 · FY2015 · CA
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2005 · HL
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2004 · HL
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2003 · HL
HIV Protease Inhibitors and Atherosclerosis
$362,000University Of Kentucky · R01 · FY2002 · HL
Functional Analysis of ACAT
$361,982Ta-Yuan Chang · Dartmouth College · R01 · FY2007 · HL
Lipid Raft Microdomains in Neutrophil Function
$361,970Robert Gary Sitrin · University Of Michigan At Ann Arbor · R01 · FY2009 · AI
Lipid Raft Microdomains in Neutrophil Function
$361,970Robert Gary Sitrin · University Of Michigan At Ann Arbor · R01 · FY2008 · AI
Sulfotransferase Expression: Implications for Toxicity
$361,963Melissa A Runge-Morris · Wayne State University · R01 · FY2008 · ES
Development of novel tissue directed ultra sound therapeutic gene delivery system
$361,937Eric Coles · Sonogene, Llc · R44 · FY2011 · HL
Determining the Impact of SREBP on Adaptive Immunity
$361,900Steven J Bensinger · University Of California Los Angeles · R01 · FY2013 · AI
Azoles and Candida in AIDS-Transcriptional Regulation
$361,832Theodore C. White · Seattle Biomedical Research Institute · R01 · FY2006 · DE
Intestinal Disease: Enterocyte/Toxin Interaction
$361,788Children'S Hospital Boston · R01 · FY2001 · DK
Does the inhibition of key xenobiotic-metabolizing CYPs cause obesity?
$361,775William S Baldwin · Clemson University · R15 · FY2016 · ES